tiprankstipranks

MNTL Price & Analysis

Compare

MNTL ETF Chart & Stats

ETF Overview

Tema Neuroscience and Mental Health ETF

The Tema Neuroscience and Mental Health ETF (ticker: MNTL) is a sector-focused exchange-traded fund tailored for investors keen on the cutting edge of healthcare innovation. This ETF zeroes in on the dynamic world of Pharma, Biotech, and Life Sciences, with a specialized emphasis on neuroscience and mental health. Designed to capture growth opportunities within these critical areas, MNTL offers exposure to companies pioneering advancements in neurological research, mental health treatments, and related technologies. In an era where mental health awareness and neurological disorders are gaining unprecedented attention, the Tema Neuroscience and Mental Health ETF stands at the forefront, allowing investors to align their portfolios with transformative sectors that are both promising and impactful. This fund meticulously curates its holdings to encompass top-performing firms that are revolutionizing how we understand and treat mental and neurological health. Whether you're an investor seeking to capitalize on the explosive growth potential of biotech breakthroughs or someone passionate about the societal importance of mental health, MNTL provides a focused gateway into the future of healthcare solutions.
Asset Class
Equity
Region
Global
Issuer
Tema
Index Tracked
No Underlying Index
Ticker Symbol
MNTL

Tema Neuroscience and Mental Health ETF (MNTL) Fund Flow Chart

Tema Neuroscience and Mental Health ETF (MNTL) 1 year Net Flows: $7M

MNTL ETF FAQ

What was MNTL’s price range in the past 12 months?
MNTL lowest ETF price was $23.67 and its highest was $27.66 in the past 12 months.
    What is the AUM of MNTL?
    As of Jan 29, 2025 The AUM of MNTL is 11.25M.
      Is MNTL overvalued?
      According to Wall Street analysts MNTL’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does MNTL pay dividends?
        MNTL pays a Notavailable dividend of $0.256 which represents an annual dividend yield of 1.01%. See more information on MNTL dividends here
          How many shares outstanding does MNTL have?
          MNTL has 440,000 shares outstanding.
            Which hedge fund is a major shareholder of MNTL?
            Currently, no hedge funds are holding shares in MNTL

            MNTL ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Vertex Pharmaceuticals Inc.
            8.54%
            Neurocrine Biosciences
            5.15%
            Argenx
            5.13%
            Eli Lilly And Company
            5.05%
            Alnylam Pharmaceuticals
            4.92%
            Teva Pharmaceutical Industries Limited
            4.91%
            Regeneron Pharmaceuticals
            3.97%
            Biogen Inc.
            3.23%
            Medtronic
            3.17%
            UCB
            UCB SA
            3.10%
            Total47.18%
            See All Holdings
            Popular ETFs
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis